Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00432-015-2072-5
Published Online: 2015-11-18
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Hyori
Youk, Jeonghwan
Yang, Yaewon
Kim, Tae-Yong
Min, Ahrum
Ham, Hye-Seon
Cho, Seongcheol
Lee, Kyung-Hun
Keam, Bhumsuk
Han, Sae-Won
Oh, Do-Youn
Ryu, Han Suk
Han, Wonshik
Park, In Ae
Kim, Tae-You
Noh, Dong-Young
Im, Seock-Ah
Text and Data Mining valid from 2015-11-18